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1. Introduction
  Much research has been done worldwide to identify 
and study antibacterial compounds found in medicinal 
plants[1-3]. According to Ríos and Recio[4], studies using 
essential oils or isolated compounds such as alkaloids, 
flavonoids, sesquiterpenes, lactones, diterpenes, 
triterpenes and naphtoquinones to test antibacterial effects 
are necessary to validate the use of a range of popular 
medicines. 
  The moringa tree (Moringa oleifera), a phanerogamous 
plant native to India, has been the object of extensive study 
due to its multiple uses as raw material in the production of 
oils, foods, condiments and drugs[5]. Studies on this plant 
have revealed promising anti-inflammatory[6], antifungal[7], 
pro-coagulant[8], flocculating[9] and antibacterial[10] 
properties. The latter has been attributed to different parts 
of the plant, such as the leaves, roots, seeds, flowers, fruit 
peel and unripe pods[11].
  The objective of the present study was to evaluate the 
antibacterial effect of aqueous and ethanolic moringa 
leaf extracts on the growth of Escherichia coli (E. coli), 
Staphylococcus aureus (S. aureus), Vibrio parahaemolyticus 
(V. parahaemolyticus) , Enterococcus faecalis (E. faecalis), 
Pseudomonas aeruginosa (P. aeruginosa) , Salmonella 
enteritidis (S.  enteritidis) and Aeromonas caviae (A. caviae)
2. Materials and methods
2.1. Preparation of extracts
  The experiments used leaves of Moringa oleifera 
(M. oleifera) Lam. supplied by the Nutrition and Food 
Production Center (NUNPRA) of the Vale do Acaraú 
State University (UVA). A specimen was deposited in the 
herbarium of the same institution under entry number of 
5823. To prepare the aqueous extracts, 10 g and 20 g of 
Moringa leaves were homogenized in a magnetic stirrer 
with 190 mL and 180 mL sterile distilled water, respectively. 
The ethanolic extracts were prepared by homogenizing 10 g 
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e 20 g of Moringa leaves in 190 mL and 180 mL solution 
containing 50% sterile distilled water and 50% ethanol p.a., 
respectively. Paper disks were soaked with 100, 200, 300 
and 400毺L filtered homogenate and used immediately for 
susceptibility testing.
2.2. Bacteria
  The antibacterial effect of the extracts was tested on 
the strains E. coli (ATCC25922), S. aureus (ATCC25923), V. 
parahaemolyticus, E. faecalis (ATCC29212), P. aeruginosa 
(ATCC27853), S. enteritidis (IH) and A. caviae supplied 
by the microbe bank of the Laboratory of Seafood and 
Environmental Microbiology (LABOMAR/UFC). 
2.3. Antibacterial activity
  Ten susceptibility tests were performed using the modified 
disk diffusion method[12]. Following adjustment to the 0.5 
McFarland turbidity standard (108 CFU/mL)[13], the selected 
strains were seeded in Mueller Hinton agar (Difco). Aliquots 
were spread on disks soaked with different volumes and 
concentrations of extract and incubated at 35 曟 for 24 hours. 
Following incubation, the inhibition halos were measured 
with a caliper. Strains were considered to be susceptible 
when the diameter of the halo measured ≥13 mm[14].
3. Results 
  The strains E. coli, P. aeruginosa and S. enteritidis (IH) 
were resistant to all treatments (Table 1). Table 1 shows the 
results of the antibiogram for aqueous and ethanolic extracts 
at the concentration of 20 g/180 mL. The most promising 
results were those for disks with 400μL extract, producing 
halos measuring on the average 23.3 mm (S. aureus), 19.4 
mm (E. faecalis), 23.8 mm (A. caviae) and 21.9 mm (V. 
parahaemolyticus). The corresponding values for aqueous 
extracts were 25.4 mm, 17.8 mm, 22.3 mm and 20.7 mm.
  At the concentration of 10 g/190 mL (Table 2), ethanolic 
extracts produced halos measuring 9–23mm. Disks with 
400 毺L extract displayed the largest halos: 22.3 mm (S. 
aureus), 17.0 mm (E. faecalis), 21.2 mm (A. caviae) and 17.8 mm 
(V. parahaemolyticus). 
  Aqueous extracts produced halos measuring 9-26 mm. 
Disks with 400毺L extract displayed the largest average 
halos for S. aureus (22.0 mm), A. caviae (21.4 mm) and V. 
parahaemolyticus (20.7 mm). However, the largest average 
halos for E. faecalis (16.3 mm) were observed for disks with 
300 毺L.
  The variance analysis (Table 3) revealed a statistically 
significant relation between the variables (cells, extract, 
concentration and volume) and the size of the inhibition 
halo at the level of 1% and 5% probability for the species 
V. parahaemolyticus, A. caviae and E. faecalis. The relation 
between the variable ‛extract’ and halo size was not 
significant for S. aureus (P>0.05).  
4. Discussion
  The strains E. coli, P. aeruginosa and S. enteritidis (IH) 
were resistant to all treatments. The observed resistance of 
E. coli matches findings from a study on the antibacterial 
Table 1
 Susceptibility of E. coli, S. aureus, V. parahaemolyticus, E. faecalis, P. aeruginosa, S. enteritidis and A. caviae to aqueous and ethanolic Moringa 




Min Max Mean Min Max Mean
S. aureus 100 15.0 20.0 17.9 12.0 25.0 16.5
200 19.0 21.0 19.9 15.0 30.0 19.8
300 20.0 27.0 22.3 16.0 35.0 22.9
400 22.0 27.0 23.3 19.0 38.0 25.4
E. faecalis 100 14.0 16.0 14.4 12.0 15.0 30.0
200 15.0 18.0 16.7 13.0 17.0 14.9
300 16.0 19.0 18.2 14.0 20.0 16.4
400 18.0 21.0 19.4 16.0 20.0 17.8
A. caviae 100 16.0 24.0 20.2 16.0 17.0 16.4
200 18.0 25.0 21.9 16.0 20.0 18.4
300 20.0 26.0 23.4 17.0 22.0 20.4
400 20.0 26.0 23.8 21.0 25.0 22.3
V. parahaemolyticus 100 11.0 19.0 15.5 15.0 18.0 15.9
200 12.0 22.0 18.7 16.0 21.0 18.3
300 20.0 22.0 20.8 17.0 22.0 20.0
400 20.0 23.0 21.9 17.0 24.0 20.7
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properties of Indian plants showing Moringa extracts to 
be ineffective against E. coli[15]. Rajendrhan et al.[16] also 
reported E. coli to be resistant to Moringa extracts. 
  Doughari et al.[10] observed inhibition halos up to 8 mm when 
challenging Salmonella with aqueous and ethanolic Moringa 
leaf extracts. The authors attributed the antibacterial effect 
to the presence of saponine, tannic, phenolic and alkaloid 
phytoconstituents. However, due to the absence in our study 
of antibacterial activity against Salmonella, their findings 
cannot be compared to ours.  
  The antibacterial activity of the extract was greater 
against gram-positive species (S. aureus and E. faecalis) 
than against gram-negative strains (E. coli, Salmonella, 
P. aeruginosa, V. parahaemolyticus and A. caviae). Similar 
effects have been reported for other medicinal plant extracts 
in several studies[17-19].
  Cáceres et al.[20] found Moringa leaf extracts (M. oleifera) 
can inhibit the growth of S. aureus and P. aeruginosa. 
Likewise, in a study by Valsaraj et al.[21] evaluating the 
antibacterial effect of 78 plants used in India to treat 
infectious diseases, P. aeruginosa and S. aureus were 
inhibited by extracts of Moringa peel. In the present 
study, aqueous and ethanolic Moringa leaf extracts had an 
antibacterial effect on S. aureus, but not on P. aeruginosa.
  E. faecalis was susceptible to all the extracts tested, 
contrary to findings published by Suarez et al.[22-26] who 
found Moringa extracts to be ineffective against E. faecalis 
isolated from clinical samples. On the other hand, their 
extracts produced bacteriostatic and bactericidal effects on 
S. aureus. 
  The susceptibility of V. parahaemolyticus to aqueous and 
ethanolic Moringa leaf extracts suggests the presence of 
vibriocidal compounds. In a study testing 60 medicinal 
plants (including Moringa pterygosperma) for activity 
against vibrios, Sharma et al.[27] only identified three species 
with antivibrio properties: Syzygium cumini, Lawsonia 
inermis and Terminalia bellerica. The authors attributed the 
antibacterial effect on V. cholerae and V. parahaemolyticus 
to the presence of gallic acid and tannin.
  Obi et al.[28] evaluated the susceptibility profiles of 
aeromonad bacteria to medicinal plant extracts and found 
the species A. hydrophila, A. sobria and A. caviae to be 
Table 2
Susceptibility of E. coli, S. aureus, V. parahaemolyticus, E. faecalis, P. aeruginosa, S. enteritidis and A. caviae to aqueous and ethanolic Moringa 




Min Max Mean Min Max Mean
S. aureus 100 15.0 20.0 17.3 11.0 20.0 15.2
200 17.0 21.0 18.5 15.0 23.0 18.6
300 19.0 23.0 21.3 16.0 25.0 20.2
400 20.0 24.0 22.3 18.0 26.0 22.0
E. faecalis 100   9.0 12.0 10.8   8.0 17.0 12.1
200 12.0 15.0 13.9 11.0 18.0 13.4
300 15.0 17.0 16.1 13.0 21.0 16.3
400 16.0 19.0 17.0 13.0 20.0 16.1
A. caviae 100 14.0 18.0 16.3 13.0 19.0 15.6
200 17.0 21.0 19.5 18.0 21.0 18.8
300 18.0 22.0 20.2 10.0 24.0 19.1
400 19.0 23.0 21.2 17.0 25.0 21.4
V. parahaemolyticus 100 13.0 15.0 14.3 15.0 17.0 15.7
200 15.0 23.0 16.7 17.0 19.0 17.6
300 16.0 24.0 17.5 17.0 20.0 19.0
400 17.0 20.0 17.8 18.0 22.0 20.7
Table 3
Variance analysis of susceptibility of E. coli. S. aureus. V. arahaemolyticus. E. faecalis. P. aeruginosa. S. enteritidis and A. caviae to aqueous and 
ethanolic Moringa leaf extracts. 
SV
S. aureus V. parahaemolyticus A. caviae E. faecalis
SS DF MS F P SS DF MS F P SS DF MS F P SS DF MS F P
Cells 1152.98 15 76.86 5.291 < 0.01 743.89 15 49.59 23.104 < 0.01 1001.18 15 66.74 18.853 < 0.01 819.49 15 54.64 22.407 < 0.01
Extract 3.03 1 3.03 0.208 > 0.05 13.81 1 13.81 6.432 < 0.05 184.90 1 184.90 52.228 < 0.01 26.41 1 26.41 10.830 < 0.01
Concentration 99.22 1 99.22 6.831 < 0.05 97.66 1 97.66 45.495 < 0.01 202.50 1 202.50 57.199 < 0.01 142.51 1 142.51 58.447 < 0.01
Volume 982.13 3 327.38 22.537 < 0.01 553.37 3 184.46 85.932 < 0.01 445.48 3 148.49 41.944 < 0.01 599.57 3 199.86 81.969 < 0.01
Interaction 68.60 10 6.86 0.472 > 0.05 79.06 10 7.91 3.683 < 0.05 168.30 10 16.83 4.753 < 0.05 51.00 10 5.10 2.092 < 0.05
Error 2091.80 144 14.53   309.10 144 2.15   509.80 144 3.54   351.10 144 2.44   
* SV: Sources of variation. SS: Sum of squares. DF: Degree of freedom. MS: Mean square. 
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sensitive to extracts of Pterocarpus angolensis, Syzygium 
cordatum and Zornia milneana. This indicates a potential 
alternative use for medicinal plants in the treatment of 
infections involving Aeromonas-a possibility supported by 
the susceptibility of A. caviae to Moringa extracts observed 
in the present study.
  In conclusion, aqueous and ethanolic Moringa leaf extracts 
were shown to contain compounds with wide-spectrum 
antibacterial activity, capable of inhibiting the growth of 
gram-positive and negative bacteria.
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